About
BioProtect is a biotechnology company based in Tzur Yigal, Israel, that specializes in developing biodegradable implantable balloon solutions. Founded in 2004, the company focuses on enhancing safety during radiation oncology treatments, particularly for prostate cancer. Their flagship product, the BioProtect Balloon Implant System, is FDA-cleared for rectal protection during radiation therapy and has been successfully used in over 2,000 patients globally. The BioProtect Balloon is a saline-filled, biodegradable device that creates a safe space between the prostate and rectum, significantly reducing radiation exposure to healthy tissues. It is designed for easy implantation under ultrasound guidance and can be adjusted to optimize organ separation. BioProtect aims to support healthcare providers with clinical data and imaging assistance to improve treatment planning. With a dedicated team and recent funding to expand in the U.S. market, BioProtect continues to innovate in the field of radiation oncology.
Technologies
Keywords
Company Information
- Employees110
- Founded2004
- Annual Revenue$5000000
- Total Funding$69500000
Location
6 Ha-Gavish Street, Netanya, Center District, Israel
